This is reminiscent of a report from Ajona and colleagues, who demonstrated that the combined inhibition of IGF1R and PD-1 synergistically reduced tumor growth in mice injected with non-small-cell lung cancer (NSCLC) cells [85]. This evidence concerns the gene IGF1R and neoplasm.